Here, we focused on memory-formed bystander T cells, and considered their viral-specific responses in a relapsed/refractory diffuse large B-cell lymphoma patient who developed adenoviral hemorrhagic cystitis as an uncommon complication after CD19 CAR-T cell therapy following CD20 BsAb therapy. This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.